MCID: BSL006
MIFTS: 47

Basaloid Squamous Cell Carcinoma malady

Category: Cancer diseases

Aliases & Classifications for Basaloid Squamous Cell Carcinoma

About this section

Aliases & Descriptions for Basaloid Squamous Cell Carcinoma:

Name: Basaloid Squamous Cell Carcinoma 10 12 65
 
Basaloid Carcinoma 10 65

Classifications:



External Ids:

Disease Ontology10 DOID:5522
SNOMED-CT59 128634009
NCIt42 C54244
UMLS65 C1266005, C1704216

Summaries for Basaloid Squamous Cell Carcinoma

About this section
Disease Ontology:10 A squamous cell carcinoma that has a solid, closely packed growth of cells with hyperchromatic nuclei, scant cytoplasm, small cystic spaces, and foci of necrosis. It has overlying squamous dysplasia, rare foci of overt keratinization, and/or coexistent keratinizing squamous cell carcinoma.

MalaCards based summary: Basaloid Squamous Cell Carcinoma, also known as basaloid carcinoma, is related to esophageal basaloid squamous cell carcinoma and cervical basaloid squamous cell carcinoma. An important gene associated with Basaloid Squamous Cell Carcinoma is KRT14 (Keratin 14), and among its related pathways are Inhibition of Ribosome Biogenesis by p14(ARF) and Oncogene Induced Senescence. Affiliated tissues include prostate, breast and skin, and related mouse phenotypes are hearing/vestibular/ear and pigmentation.

Related Diseases for Basaloid Squamous Cell Carcinoma

About this section

Diseases related to Basaloid Squamous Cell Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 153)
idRelated DiseaseScoreTop Affiliating Genes
1esophageal basaloid squamous cell carcinoma12.4
2cervical basaloid squamous cell carcinoma12.2
3vulvar basaloid squamous cell carcinoma12.2
4anus basaloid carcinoma12.1
5thymus basaloid carcinoma12.0
6penis basaloid carcinoma12.0
7basaloid squamous cell skin carcinoma11.2
8spinal cord astrocytoma10.6CDKN2A, TP53
9deep leiomyoma10.6CDKN2A, TP53
10splenogonadal fusion limb defects micrognatia10.6CDKN2A, TP53
11basaloid squamous cell carcinoma10.6CDKN2A, TP53
12chronic rhinitis10.6CDKN2A, TP53
13myotonia congenita10.6CDKN2A, TP53
14middle ear squamous cell carcinoma10.6CDKN2A, TP53
15anal paget's disease10.6CDKN2A, TP53
16renal pelvis squamous cell carcinoma10.5CDKN2A, TP53
17hepatopulmonary syndrome10.5CDKN2A, TP53
18spastic ataxia 210.5CDKN2A, TP53
19peroxisomal disease10.5CDKN2A, TP53
20cervical verrucous carcinoma10.5CDKN2A, TP53
21apocrine adenocarcinoma10.5CDKN2A, TP53
22benign mesenchymoma10.5CDKN2A, TP53
23basophilic carcinoma10.5CDKN2A, TP53
24vulva verrucous carcinoma10.5CDKN2A, TP53
25recessive dystrophic epidermolysis bullosa-generalized other10.5CDKN2A, TP53
26substance abuse10.5KRT14, TP53
27gastrointestinal neuroendocrine tumor10.5CDKN2A, TP53
28variola minor10.5KRT14, KRT4
29acute pancreatitis10.5CDKN2A, TP53
30sebaceous adenocarcinoma10.5KRT14, TP63
31childhood pilocytic astrocytoma10.5CDKN2A, TP53
32progressive muscular atrophy10.4CDKN2A, TP53
33schwannoma of twelfth cranial nerve10.4CDKN2A, TP53
34anhidrosis10.4KRT14, TP63
35microglandular adenosis10.4ENG, TP53
36bilateral breast cancer10.4CDKN2A, TP53
37lymphatic system disease10.4EGFR, TP53
38laryngitis10.4
39hypogonadotropic hypogonadism-frontoparietal alopecia syndrome10.4EGFR, TP53
40spondylitis10.4EGFR, KRT14
41vulvar sarcoma10.4KRT14, TP53
42nasal cavity squamous cell carcinoma10.4EGFR, KRT14
43adult medulloblastoma10.4TP53, TP63
44gestational trophoblastic neoplasm10.4CDKN2A, TP53
45cervical non-keratinizing squamous cell carcinoma10.4EGFR, TP53
46dental pulp necrosis10.4CDKN2A, TP53
47brain stem cancer10.3EGFR, TP53
48embryoma10.3EGFR, TP53
49adenoiditis10.3
50esophagitis10.3

Graphical network of the top 20 diseases related to Basaloid Squamous Cell Carcinoma:



Diseases related to basaloid squamous cell carcinoma

Symptoms for Basaloid Squamous Cell Carcinoma

About this section

Drugs & Therapeutics for Basaloid Squamous Cell Carcinoma

About this section

Drugs for Basaloid Squamous Cell Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 25)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
FluorouracilapprovedPhase 3, Phase 2, Phase 1168451-21-83385
Synonyms:
1-fluoro-1h-pyrimidine-2,4-dione
1004-03-1
1upf
2,4-Dihydroxy-5-fluoropyrimidine
2,4-Dioxo-5-fluoropryimidine
2,4-Dioxo-5-fluoropyrimidine
47576_FLUKA
4921-97-5
5 FU Lederle
5 FU medac
5 Fluorouracil
5 Fluorouracil biosyn
5 HU Hexal
5-FU
5-FU (TN)
5-FU Lederle
5-FU medac
5-Faracil
5-Fluor-2,4(1H,3H)-pyrimidindion
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]
5-Fluor-2,4-dihydroxypyrimidin
5-Fluor-2,4-dihydroxypyrimidin [Czech]
5-Fluor-2,4-pyrimidindiol
5-Fluor-2,4-pyrimidindiol [Czech]
5-Fluoracil
5-Fluoracil [German]
5-Fluoracyl
5-Fluoro-2,4(1H,3H)-pyrimidinedione
5-Fluoro-2,4-pyrimidinedione
5-Fluoropyrimidin-2,4-diol
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluoruracil
5-Fluoruracil [German]
5-Fluracil
5-Ftouracyl
5-HU Hexal
5-fluoro uracil
5-fluoro-1H-pyrimidine-2,4-dione
5-fluoropyrimidine-2,4(1H,3H)-dione
5-fluorouracil
51-21-8
5FU
79108-01-3
AC-11201
AC1L1FTE
AC1Q4N2X
AI3-25297
AKOS000119162
AKOS003237897
AccuSite
Actino-Hermal
Adrucil
Adrucil (TN)
Allergan Brand of Fluorouracil
Arumel
BB_NC-0576
BSPBio_002048
C07649
C4H3FN2O2
CCRIS 2582
CHEBI:46345
CHEMBL185
CID3385
CPD0-1327
CPD000038082
CSP Brand of Fluorouracil
Carac
Carac (TN)
Carzonal
Cinco FU
Cytosafe
D005472
D00584
DB00544
Dakota Brand of Fluorouracil
Dakota, Fluorouracile
Dermatech Brand of Fluorouracil
Dermik Brand of Fluorouracil
DivK1c_000054
EINECS 200-085-6
EU-0100536
Effluderm
Effluderm (free base)
Efudex
Efudix
Efurix
F 6627
F0151
F6627_SIGMA
F8423_SIGMA
FT-0082524
FU
Ferrer Brand of Fluorouracil
Fiverocil
Fluoro Uracil
Fluoro Uracile ICN
Fluoro-Uracile ICN
Fluoro-uracile
Fluoro-uracilo
Fluoroblastin
Fluoroplex
Fluoroplex (TN)
Fluorouracil
Fluorouracil (JP15/USP/INN)
Fluorouracil GRY
Fluorouracil Mononitrate
Fluorouracil Monopotassium Salt
Fluorouracil Monosodium Salt
Fluorouracil Potassium Salt
Fluorouracil Teva Brand
Fluorouracil [USAN:INN:BAN:JAN]
 
Fluorouracil-GRY
Fluorouracile
Fluorouracile Dakota
Fluorouracile [DCIT]
Fluorouracilo
Fluorouracilo Ferrer Far
Fluorouracilo [INN-Spanish]
Fluorouracilum
Fluorouracilum [INN-Latin]
Fluoruracil
Fluouracil
Flurablastin
Fluracedyl
Fluracil
Fluracilum
Fluri
Fluril
Fluro Uracil
Fluroblastin
Flurodex
Flurouracil
Flurox
Ftoruracil
Gry Brand of Fluorouracil
HMS1920O18
HMS2090I04
HMS2091F19
HMS500C16
HSDB 3228
Haemato Brand of Fluorouracil
Haemato fu
Haemato-fu
Hexal Brand of Fluorouracil
I07-0022
ICN Brand of Fluorouracil
IDI1_000054
IN1335
KBio1_000054
KBio2_001321
KBio2_003889
KBio2_006457
KBio3_001268
KBioGR_001253
KBioSS_001321
Kecimeton
LS-153
Lopac-F-6627
Lopac0_000536
MLS000069498
MLS002415705
MolPort-000-156-102
MolPort-003-990-447
MolPort-004-758-143
MolPort-004-758-144
MolPort-005-861-486
NCGC00015442-01
NCGC00015442-03
NCGC00015442-10
NCGC00091349-01
NCGC00091349-02
NCGC00091349-03
NCGC00091349-04
NCGC00091349-05
NCGC00091349-07
NCGC00091349-08
NCI60_001652
NINDS_000054
NSC 19893
NSC-19893
NSC19893
Neocorp Brand of Fluorouracil
Neofluor
Onkofluor
Onkoworks Brand of Fluorouracil
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Riemser Brand of Fluorouracil
Ro 2-9757
Ro-2-9757
Roche Brand of Fluorouracil
S1209_Selleck
SAM002264615
SMR000038082
SPBio_000291
SPECTRUM1500305
STK297802
Spectrum2_000076
Spectrum3_000434
Spectrum4_000557
Spectrum5_000718
Spectrum_000841
T5233394
TL8006093
Teva Brand of Fluorouracil
Timazin
U 8953
U-8953
UNII-U3P01618RT
UPCMLD-DP130
UPCMLD-DP130:001
URF
Ulup
WLN: T6MVMVJ EF
ZINC00897110
biosyn Brand of Fluorouracil
fluorouracil
inhibits thymilidate synthetase
medac Brand of Fluorouracil
nchembio.90-comp3
nchembio809-comp6
ribosepharm Brand of Fluorouracil
tetratogen
2
CisplatinapprovedPhase 3, Phase 2, Phase 1254015663-27-184093, 441203, 2767
Synonyms:
(SP-4-1)-diamminedichloridoplatinum
(SP-4-1)-diamminedichloroplatinum
(SP-4-2)-diamminedichloridoplatinum
(SP-4-2)-diamminedichloroplatinum
Abiplatin
Biocisplatinum
Briplatin
CACP
CDDP
CHEBI:35852
CID441203
CPD0-1392
CPDC
CPDD
Carboquone
Cis Pt II
Cis-DDP
Cis-Diaminedichloroplatinum
Cis-Diamminedichloroplatinum
Cismaplat
Cisplatin
Cisplatine
Cisplatino
Cisplatinum
Cisplatyl
Citoplationo
DB00515
DDP
DDPT
Diamminedichloroplatinum
 
EU-0100918
Lederplatin
Neoplatin
Peyrone's chloride
Peyrone's salt
Plastin
Platamine
Platiblastin
Platidiam
Platinex
Platinol
Platinol-AQ
Platinol-aq
Platinoxan
Platinum Ammine Chloride
Platinum Ammonium Chloride
Platinum Diamine Dichloride
Randa
Trans-DDP
Trans-Diaminedichloroplatinum
Trans-Diamminedichloroplatinum
Trans-Dichlorodiammine Platinum
Trans-Platinumdiammine Dichloride
cis-DDP
cis-Diamminedichloroplatinum
cis-Dichlorodiammineplatinum(II)
cis-[PtCl2(NH3)2]
cis-diamminedichloridoplatinum(II)
cis-diamminedichloroplatinum(II)
nchembio773-comp1
trans-diamminedichloridoplatinum(II)
3Immunologic FactorsPhase 3, Phase 218483
4Nucleic Acid Synthesis InhibitorsPhase 3, Phase 23836
5Alkylating AgentsPhase 3, Phase 23582
6MitomycinsPhase 3, Phase 2219
7Immunosuppressive AgentsPhase 3, Phase 210422
8Antimetabolites, AntineoplasticPhase 3, Phase 25770
9Antibiotics, AntitubercularPhase 3, Phase 25971
10Anti-Bacterial AgentsPhase 3, Phase 29140
11AntimetabolitesPhase 3, Phase 29454
12
CarboplatinapprovedPhase 2, Phase 1188541575-94-410339178, 498142, 38904
Synonyms:
(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum
/h1-3H2,(H,7,8)(H,9,10)
/q
1,1-Cyclobutanedicarboxylate diammine platinum (II)
1,1-Cyclobutanedicarboxylate diammine platinum(II)
2*-1
2*1H2
41575-94-4
70903-55-8
AC-1457
AC1L8I6U
Ambap41575-94-4
BSPBio_003145
C 2538
C2043
C2538_SIGMA
C6H10N2O4Pt
CBDCA
CCRIS 3404
CHEBI:31355
CHEMBL1351
CHEMBL288376
CID10339178
CID2567
CID38904
CID426756
CID498142
CID5352133
CID6398587
CID6603770
Carbopaltin
Carboplatin
Carboplatin (JAN/USP/INN)
Carboplatin (USAN)
Carboplatin [USAN:INN:BAN:JAN]
Carboplatine
Carboplatine [French]
Carboplatino
Carboplatino [Spanish]
Carboplatinum
Carboplatinum [Latin]
Cbdca
Cyclobutane-1,1-dicarboxylate
D01363
DB00958
Diammine(1,1-cyclobutanedicarboxylato)platinum (II)
Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum
Diammine-1,1-cyclobutane dicarboxylate platinum II
DivK1c_000892
EINECS 255-446-0
EU-0100230
Ercar
HMS1921J16
HMS2090M05
HMS2092B22
HMS502M14
HSDB 6957
I14-2390
IDI1_000892
IUPAC: Azane
InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6
 
JM 8
JM-8
KBio1_000892
KBio2_002009
KBio2_004577
KBio2_007145
KBio3_002645
KBioGR_000713
KBioSS_002009
LS-117689
Lopac-C-2538
Lopac0_000230
MolPort-003-665-501
MolPort-003-845-609
NCGC00015223-01
NCGC00093695-01
NCGC00094961-01
NCGC00094961-02
NCGC00094961-03
NCGC00162099-01
NCGC00162099-02
NCGC00167800-01
NCGC00178242-01
NINDS_000892
NSC 201345
NSC 241240
NSC-241240
NSC201345
NSC241240
Paraplatin
Paraplatin (TN)
Paraplatin, Carboplatin
Paraplatin-AQ
Platinum(+2) Cation
Platinum(II), (1, 1-cyclobutanedicar
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)
Platinum, {diammine[1,1-cyclobut
S1215_Selleck
SPBio_000716
SPECTRUM1502106
Spectrum2_000898
Spectrum3_001503
Spectrum4_000337
Spectrum5_001094
Spectrum_001529
UNII-BG3F62OND5
azanide
carboplatin
cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii)
cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)
cis-Diammine(1,1-cyclobutanedicarboxylato) platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diammine(cyclobutanedicarboxylato)platinum II
cyclobutane-1,1-dicarboxylic acid
diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum
nchembio.573-comp10
nchembio773-comp2
nchembio873-comp3
platinum(2+)
13
Capecitabineapproved, investigationalPhase 21220154361-50-960953
Synonyms:
(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester
154361-50-9
158798-73-3
5'-Deoxy-5-fluoro-N-((pentyloxy)carbonyl)cytidine
5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine
AC1L1U83
AC1Q4KU8
Ambap154361-50-9
C110904
C12650
C15H22FN3O6
CAPE
CAPECITABINE
CHEBI:31348
CHEMBL1773
CID60953
Capecitabin
Capecitabina
Capecitabine
Capecitabine (JAN/USAN/INN)
Capecitabine [USAN]
Capecitabinum
Capecitibine
Capiibine
Carbamic acid, (1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-, pentyl ester
Caxeta
 
D01223
DB01101
FT-0082472
HSDB 7656
LS-59070
MolPort-005-938-254
N(4)-Pentyloxycarbonyl-5'-deoxy-5-fluorocytidine
Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate
Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate
R-340
R340
RG-340
Ro 09-1978
Ro 09-1978/000
Ro-09-1978
Ro-09-1978/000
S1156_Selleck
UNII-6804DJ8Z9U
Xabine
Xeloda
Xeloda (TN)
Xeloda, Captabin, Capecitabine
ZINC03806413
capecitabina
capecitabine
capecitabinum
pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate
14
CetuximabapprovedPhase 2, Phase 1713205923-56-456842117, 2333
Synonyms:
205923-56-4
Anti EGFR
Cetuximab
Cetuximab (USAN/INN)
Cetuximab (genetical recombination)
 
Cetuximab (genetical recombination) (JAN)
D03455
Erbitux
Erbitux (TN)
IMC-C225
cetuximab
15
PaclitaxelapprovedPhase 2, Phase 1262133069-62-436314
Synonyms:
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
157069-30-2
33069-62-4
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.
7-Epi-Paclitaxel
7-Epi-Taxol
7-Epipaclitaxel
7-Epitaxol
7-epi-Paclitaxel
7-epi-Taxol
AB00513812
ABI 007
ABI-007
ABI007
AC-675
AC1L1IOG
AC1L1VJI
AC1L9AVF
ACon1_002231
ANX-513
Abraxane
Abraxane (TN)
Abraxane I.V. Suspension
Abraxis BioScience brand of albumin-bound paclitaxel
Ambotz33069-62-4
Anzatax
Asotax
BIDD:PXR0046
BMS 181339-01
BMS-181339
BMS-181339-01
BPBio1_000320
BRD-A23723433-001-01-2
BRD-A28746609-001-04-0
BRD-K62008436-001-03-1
BSPBio_000290
BSPBio_001152
BSPBio_002614
Bio-0076
Bio1_000362
Bio1_000851
Bio1_001340
Bio2_000416
Bio2_000896
Bristaxol
C07394
C466458
C47H51NO14
CCRIS 8143
CHEBI:103439
CHEBI:45863
CHEMBL100910
CHEMBL418410
CHEMBL48
CID36314
CID441276
CID4666
CID6713921
CID6915727
CPD-8718
Capxol
D00491
DB01229
DHP-107
DHP-208
DRG-0190
DTS-301
DivK1c_000441
EU-0101201
Ebetaxel
EmPAC
Epitaxol
Genaxol
Genetaxyl
Genexol
Genexol-PM
HMS1362J13
HMS1568O12
HMS1792J13
HMS1922K08
HMS1990J13
HMS2090D07
HMS2093K15
HMS501G03
HSDB 6839
I06-0014
IDI1_000441
IDI1_002171
Intaxel
KBio1_000441
KBio2_000492
KBio2_002016
KBio2_002509
KBio2_003060
KBio2_004584
KBio2_005077
KBio2_005628
KBio2_007152
KBio2_007645
KBio3_000903
KBio3_000904
KBio3_001834
KBio3_002987
KBioGR_000492
KBioGR_001893
 
KBioGR_002509
KBioSS_000492
KBioSS_002016
KBioSS_002517
LMPR0104390001
LS-31070
LipoPac
Lopac0_001201
MBT 0206
MEGxp0_001940
MLS000863266
MLS001077297
MLS002154218
MLS002172439
MLS002695976
MPI-5018
Micellar Paclitaxel
Mitotax
MolPort-001-742-627
MolPort-003-665-783
MolPort-003-932-365
NCGC00024995-02
NCGC00024995-03
NCGC00024995-04
NCGC00024995-05
NCGC00024995-06
NCGC00024995-07
NCGC00164367-01
NCGC00164367-02
NCGC00164367-03
NCI60_000601
NINDS_000441
NK 105
NP-010981
NSC 125973
NSC-125973
NSC125973
NSC358882
Nanotaxel
Neuro_000060
Nova-12005
OAS-PAC-100
OncoGel
Onxal
Onxol
Onxol, Taxol, Nov-Onxol, Paclitaxel
P1632
Paclical
Pacligel
Paclitaxel
Paclitaxel (JAN/USP)
Paclitaxel (JAN/USP/INN)
Paclitaxel (Taxol)
Paclitaxel [USAN:INN:BAN]
Paxceed
Paxene
Paxoral
Plaxicel
Praxel
Prestwick0_000155
Prestwick1_000155
Prestwick2_000155
Prestwick3_000155
Probes2_000350
QW 8184
S-8184 Paclitaxel Injectable Emulsion
S1150_Selleck
SDCCGMLS-0066823.P001
SDP-013
SMP1_000228
SMR000394086
SMR000857385
SPBio_000943
SPBio_002229
SPECTRUM1503908
ST50306996
Spectrum2_000872
Spectrum3_001057
Spectrum4_001197
Spectrum5_001491
Spectrum_001536
T 7402
T1912_SIGMA
T7191_SIGMA
T7402_SIGMA
TA1
TAXOL (TN)
TAXOL, 10-EPI,
TXL
TaxAlbin
Taxol
Taxol A
Taxol Konzentrat
Taxol.RTM. (Registered Trademark)
UNII-P88XT4IS4D
UPCMLD-DP108:001
UPCMLD-DP108:002
Vascular Wrap
Xorane
Yewtaxan
abi-007
albumin-bound paclitaxel
cMAP_000068
nchembio.188-comp1
nchembio.2007.34-comp9
nchembio.215-comp9
nchembio853-comp6
paclitaxel
weekly paclitaxel
16
SuccinylcholineapprovedPhase 2141306-40-15314
Synonyms:
2,2'-[(1,4-DIOXOBUTANE-1,4-DIYL)BIS(OXY)]BIS(N,N,N-TRIMETHYLETHANAMINIUM)
2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)
2ha2
2ha6
306-40-1
4-04-00-01451 (Beilstein Handbook Reference)
541-19-5 (diiodide)
55-94-7 (dibromide)
71-27-2 (dichloride)
AC1L1K2T
Anectine
BRN 1805311
C07546
C14H30N2O4
CHEBI:45652
CHEMBL703
CID5314
Choline, succinate (2:1) (ester)
Choline, succinate (ester)
DB00202
Diacetylcholine
Dicholine succinate
Ditilin
Ditiline
HMS2090P14
HSDB 3254
InChI=1/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2
L000926
LS-53328
Listenon
 
Lopac-S-8251
Lopac0_001080
Lysthenon
MolPort-002-964-486
NCGC00015971-01
NCGC00015971-03
NCGC00162336-01
Quelicin
Quelicin Preservative Free
SCK
ST50437287
STK177290
Scoline
Succicuran
Succinic acid, diester with choline
Succinic acid, diester with choline chloride
Succinocholine
Succinoylcholine
Succinyl choline
Succinylbischoline
Succinylcholine
Succinylcholine Chloride
Succinyldicholine
Sucostrin
Suxamethonium
Suxamethonium chloride
UNII-J2R869A8YF
ZINC01530820
succinylcholine
succinyldicholine
trimethyl-[2-[4-oxo-4-(2-trimethylazaniumylethoxy)butanoyl]oxyethyl]azanium diio
trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium
17Peripheral Nervous System AgentsPhase 218510
18Tubulin ModulatorsPhase 2, Phase 14279
19Antimitotic AgentsPhase 2, Phase 14296
20Albumin-Bound PaclitaxelPhase 2, Phase 12621
21Antineoplastic Agents, PhytogenicPhase 2, Phase 14294
22Neuromuscular AgentsPhase 2922
23Neuromuscular Depolarizing AgentsPhase 2116
24Neuromuscular Blocking AgentsPhase 2327
25
Docetaxelapproved, investigational, Approved May 1996Phase 11844114977-28-5148124, 9877265
Synonyms:
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (aR,bS)-b-[[(1,1-dimethylethoxy)carbonyl]amino]-a-hydroxybenzenepropanoate
(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate
01885_FLUKA
114977-28-5
4-(Acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate
4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate
AC-383
AC1L3WHJ
ANX-514
BIND-014
C11231
CHEBI:4672
CHEMBL92
CID148124
D07866
DB01248
Docefrez
Docetaxel
Docetaxel (INN)
Docetaxel anhydrous
Docetaxel, Trihydrate
EmDOC
 
HMS2089K08
InChI=1/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,5
MolPort-003-847-005
N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel
N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol
N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel
N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol
N-debenzoyl-N-Boc-10-deacetyl taxol
NSC-628503
PSMA-targeted docetaxel nanoparticle
RP-56976
SDP-014
TXL
Taxotere
Taxotere (TN)
Taxotere(R)
XRP-6976L
docetaxel
docetaxel 114977-28-5
nchembio.188-comp8
nchembio.2007.34-comp7
nchembio.573-comp11
nchembio853-comp8

Interventional clinical trials:

idNameStatusNCT IDPhase
1Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerCompletedNCT00003596Phase 3
2Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal CancerCompletedNCT00025090Phase 3
3Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerActive, not recruitingNCT00003652Phase 3
4Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal CancerRecruitingNCT02560298Phase 2
5Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal CancerRecruitingNCT00316888Phase 2
6Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and NeckActive, not recruitingNCT00570674Phase 1, Phase 2
7Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal CancerActive, not recruitingNCT00324415Phase 2
8Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal CancerActive, not recruitingNCT00423293Phase 2
9Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and NeckActive, not recruitingNCT00513383Phase 1

Search NIH Clinical Center for Basaloid Squamous Cell Carcinoma

Genetic Tests for Basaloid Squamous Cell Carcinoma

About this section

Anatomical Context for Basaloid Squamous Cell Carcinoma

About this section

MalaCards organs/tissues related to Basaloid Squamous Cell Carcinoma:

33
Prostate, Breast, Skin, Thyroid, Brain, B cells, Endothelial

Animal Models for Basaloid Squamous Cell Carcinoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Basaloid Squamous Cell Carcinoma:

38 (show all 23)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053778.8EGFR, GJA1, KRT14, TP53
2MP:00011868.3CDKN2A, EGFR, KRT14, KRT4, PTCH1, TP53
3MP:00053718.1EGFR, GJA1, PTCH1, TP53, TP63
4MP:00020067.9CDKN2A, EGFR, KRT14, PTCH1, TP53, TP63
5MP:00030127.6CDKN2A, EGFR, GJA1, PTCH1, TP53, TP63
6MP:00028737.6EGFR, ENG, GJA1, PTCH1, TP53, TP63
7MP:00053797.4CDKN2A, EGFR, GJA1, KRT14, PTCH1, TP53
8MP:00053817.4CDKN2A, EGFR, KRT14, KRT4, PTCH1, TP53
9MP:00053897.4CDKN2A, EGFR, GJA1, KRT14, PTCH1, TP53
10MP:00053807.3CDKN2A, EGFR, ENG, GJA1, PTCH1, TP53
11MP:00053847.3CDKN2A, EGFR, GJA1, KRT14, PTCH1, TP53
12MP:00053907.3CDKN2A, EGFR, GJA1, PTCH1, TP53, TP63
13MP:00053697.1CDKN2A, EGFR, ENG, GJA1, PTCH1, TP53
14MP:00053977.0CDKN2A, EGFR, ENG, GJA1, KRT14, PTCH1
15MP:00053916.9CDKN2A, EGFR, GJA1, KRT14, KRT4, PTCH1
16MP:00053886.9CDKN2A, EGFR, ENG, GJA1, KRT14, PTCH1
17MP:00053856.9CDKN2A, EGFR, ENG, GJA1, PTCH1, TP53
18MP:00053876.8CDKN2A, EGFR, GJA1, KRT14, PTCH1, TP53
19MP:00053766.8CDKN2A, EGFR, ENG, GJA1, KRT14, PTCH1
20MP:00053826.7EGFR, ENG, GJA1, KRT14, KRT4, PTCH1
21MP:00107716.5CDKN2A, EGFR, ENG, GJA1, KRT14, KRT4
22MP:00107686.3CDKN2A, EGFR, ENG, GJA1, KRT14, KRT4
23MP:00053786.2CDKN2A, EGFR, ENG, GJA1, KRT14, KRT4

Publications for Basaloid Squamous Cell Carcinoma

About this section

Articles related to Basaloid Squamous Cell Carcinoma:

(show top 50)    (show all 174)
idTitleAuthorsYear
1
Basaloid Squamous Cell Carcinoma of the Anus Revisited. (26866355)
2016
2
Basaloid Squamous Cell Carcinoma on the Skin of the Hand. (26618138)
2015
3
Basaloid Squamous Cell Carcinoma of the Ethmoid Sinus with Invasion into the Skull Base Treated with Craniofacial Resection and Adjuvant Intensity-Modulated Radiation Therapy: A Case Report. (26835192)
2015
4
Basal cell carcinoma vs basaloid squamous cell carcinoma of the skin: an immunohistochemical reappraisal. (25702956)
2015
5
Molecular Characteristics of Basaloid Squamous Cell Carcinoma of the Esophagus: Analysis of KRAS, BRAF, and PIK3CA Mutations and LINE-1 Methylation. (25691283)
2015
6
Basaloid squamous cell carcinoma of the uterine cervix: Cytological and histological features. (26391899)
2015
7
Basaloid squamous cell carcinoma of the sinonasal tract with metastasis to the liver: a case report and literature review. (25651356)
2015
8
A fatal case of primary basaloid squamous cell carcinoma in the intrahepatic bile ducts. (25400964)
2014
9
Basaloid squamous cell carcinoma of the oropharynx: Comparison of two cases and review of the literature. (25283325)
2014
10
Human papillomavirus-related basaloid squamous cell carcinoma of the bladder associated with genital tract human papillomavirus infection. (25236950)
2014
11
PTCH1 mutation is a frequent event in oesophageal basaloid squamous cell carcinoma. (25395299)
2014
12
Reply to letter to the editor regarding investigation of laryngeal basaloid squamous cell carcinoma prognosis. (24838783)
2014
13
Basaloid squamous cell carcinoma of the maxillary sinus: Report of two cases in association with cathepsin K expression. (23833636)
2013
14
Basaloid squamous cell carcinoma of the tonsil. (23930063)
2012
15
A case of long-term survival after pulmonary resection for metachronous pulmonary metastasis of basaloid squamous cell carcinoma of the esophagus. (22721697)
2012
16
Primary intracranial basaloid squamous cell carcinoma: an enigma. (23161194)
2012
17
Basaloid squamous cell carcinoma of the larynx--A systematic review. (21868181)
2012
18
A rare case of basaloid squamous cell carcinoma of the maxilla. (23303037)
2012
19
Basaloid squamous cell carcinoma of the esophagus. (22419439)
2012
20
Basaloid squamous cell carcinoma of the tonsil: report of a case and review of the literature. (23788927)
2012
21
Basaloid squamous cell carcinoma of nasopharynx: an extremely rare variety of tumour of nasopharynx. (22187772)
2011
22
Sphenoid sinus basaloid squamous cell carcinoma presenting as a sellar mass: report a case with review of the literature. (20972844)
2011
23
Basaloid squamous cell carcinoma of the upper aerodigestive tract: a single squamous cell carcinoma subtype or two distinct entities hiding under one histologic pattern? (21125290)
2011
24
Basaloid squamous cell carcinoma of retromolar trigone: A case report with review of literature. (22529579)
2011
25
Human papillomavirus-positive basaloid squamous cell carcinomas of the upper aerodigestive tract: a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma. (20236687)
2010
26
Basaloid squamous cell carcinoma: report of five cases. (20038913)
2010
27
Basaloid squamous cell carcinoma of the esophagus: assessment for high-risk human papillomavirus and related molecular markers. (19738459)
2009
28
Cytomorphologic diagnosis of basaloid squamous cell carcinoma: a case report. (19248560)
2009
29
Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. (18496144)
2008
30
Basaloid squamous cell carcinoma of the lung: a rare tumour with a rare clinical presentation. (17328988)
2007
31
Basaloid squamous cell carcinoma of the external auditory canal: case report. (17235532)
2007
32
Immunoexpression of p53, Ki-67 and E-cadherin in basaloid squamous cell carcinoma of the larynx. (15899218)
2005
33
Endoglin (CD105) expression in head and neck basaloid squamous cell carcinoma. (15966703)
2005
34
p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. (15529180)
2005
35
Case reports of basaloid squamous cell carcinoma--an aggressive variant of squamous cell carcinoma. (16758784)
2005
36
Basaloid squamous cell carcinoma of the larynx: a case report. (16444094)
2005
37
Basaloid squamous cell carcinoma of the esophagus with or without adenoid cystic features. (15387711)
2004
38
Prognoses of oral basaloid squamous cell carcinoma and squamous cell carcinoma: a comparison. (14732774)
2004
39
Basaloid squamous cell carcinoma of the head and neck. (15167048)
2004
40
Basaloid squamous cell carcinoma report of a case and review of literature. (15164662)
2003
41
Basaloid squamous cell carcinoma of the larynx. (11860655)
2002
42
Basaloid squamous cell carcinoma of the head and neck. (10983946)
2000
43
Basaloid squamous cell carcinoma occurring in the urinary bladder. (10705407)
2000
44
An isolated digital metastasis of esophageal basaloid squamous cell carcinoma. (10885705)
2000
45
The basaloid squamous cell carcinoma of the nasopharynx. (11190760)
2000
46
Metastatic laryngeal basaloid squamous cell carcinoma simulating primary small cell carcinoma of the lung on fine needle aspiration lung biopsy. A case report. (9622708)
1998
47
Basaloid squamous cell carcinoma - larynx. (23119306)
1997
48
Basaloid-squamous cell carcinoma of the floor of the mouth: characterization of a cell line. (9379426)
1997
49
Basaloid-squamous cell carcinoma of the bronchus. Report of a case with review of the literature. (7503668)
1995
50
Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immunohistochemical study of 40 cases. (1384369)
1992

Variations for Basaloid Squamous Cell Carcinoma

About this section

Expression for genes affiliated with Basaloid Squamous Cell Carcinoma

About this section
Search GEO for disease gene expression data for Basaloid Squamous Cell Carcinoma.

Pathways for genes affiliated with Basaloid Squamous Cell Carcinoma

About this section

GO Terms for genes affiliated with Basaloid Squamous Cell Carcinoma

About this section

Cellular components related to Basaloid Squamous Cell Carcinoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1keratin filamentGO:00450959.7KRT14, KRT4

Biological processes related to Basaloid Squamous Cell Carcinoma according to GeneCards Suite gene sharing:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1replicative senescenceGO:00903999.8CDKN2A, TP53
2DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorGO:00069789.7TP53, TP63
3cell agingGO:00075699.7TP53, TP63
4hair follicle developmentGO:00019429.7EGFR, TP63
5intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorGO:00427719.7TP53, TP63
6positive regulation of osteoblast differentiationGO:00456699.5GJA1, TP63
7negative regulation of cell growthGO:00303089.4CDKN2A, GJA1, TP53
8keratinocyte proliferationGO:00436169.3PTCH1, TP63
9regulation of cell proliferationGO:00421278.9EGFR, ENG, PTCH1
10epithelial cell differentiationGO:00308558.6KRT14, KRT4, TP63
11apoptotic processGO:00069158.5CDKN2A, GJA1, TP53, TP63
12positive regulation of transcription from RNA polymerase II promoterGO:00459447.9CDKN2A, EGFR, ENG, TP53, TP63

Molecular functions related to Basaloid Squamous Cell Carcinoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1ubiquitin protein ligase bindingGO:00316259.6EGFR, TP53

Sources for Basaloid Squamous Cell Carcinoma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet